As the US transition near 5 million, Fauci says the public should lower expectations on the COVID-19 vaccine



Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases for the last three decades and epidemiologist for the last four decades, was optimistic about a vaccine coming in late 2020 or early 2121, but he has also done any vaccine. Warns the public on their expectations for development.

Q&A hosted by Brown University recently told Live Stream, “The chances of being 98% are not great, meaning you should never give up on the public-health approach.” “You think of a vaccine as a tool to be able to have an epidemic no longer an epidemic, but something that is well controlled.”

Abdullah Schiaper quoted a public-health research associate at Brown as saying, “What I’m shooting is with the vaccine and good public-health measures, we can really bring it in between good control and eradication Huh.” Interview. “So that’s what a vaccine is going to do, but it’s not going to do it alone.”


The probability of being ‘98% is not very good. Which means you should never give up on the public-health approach. ‘


– Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases

Fauci has stated that he expected a coronovirus vaccine to be developed by early 2021, but previously stated that it is unlikely that a vaccine would provide 100% immunity; He stated that the best realistic results based on other vaccines would be 70% to 75% effective. The measles vaccine, he said, is most effective by providing 97% immunity.

A review of previous studies has found that, as reviewed by studies by the Mayo Clinic, the average flu vaccine is about 50% to 60% effective on average for healthy adults. “Vaccines can sometimes be less effective,” it said. “Even when the vaccine does not completely prevent the flu, it can reduce the severity of your disease.”
Fauci advocates face masks, social distancing and escape from crowded bars and indoor spaces. “If we do those things – and I’ll keep repeating it until I’m tired – those things work,” he said on the live stream on Friday. “When you have something that everyone needs to pull at the same time, if you have a weak link that doesn’t do that, it doesn’t allow you to reach the final game.”
Commissioner for Food and Drug Administration Stephen Hahn said last month that the agency would beat the coronavirus vaccine until it became 50% effective. “We all want a vaccine tomorrow, it’s unrealistic, and we all want a vaccine that is 100% effective, again unrealistic. We said 50%.” Hahn said, “It was a reasonable floor that gave the epidemic Went.”
As of Sunday, COVID-19 had infected at least 19.4 million people globally and embarrassed only 5 million people in the US, killing 727,111 people worldwide and at least 162,425 deaths in the US Dow Jones Industrial Index DJIA,
+ 0.17%
And the S&P 500 SPX,
+ 0.06%
Friday ended as investors awaited two rounds of fiscal stimulus; Nasdaq Composite Comp,
-0.87%
Refused.
related: Feeling loose about masks? think again. If everyone wore a mask today, how many lives could be saved
In the absence of a vaccine, health experts say social disturbances and masks are the only options in the form of “herd immunity” – where people who are immune are the most vulnerable in the population – for coronaviruses is not possible. COVID-19, a disease caused by the virus SARS-CoV-2, and high levels of population are required for the virus not to mutate.
Gregory Poland, who studied immunogenetics of vaccines at the Mayo Clinic, told Marketwatch in April that none of them are currently operational. “With influenza, you need 60% to 70% herd immunity. With measles, you need about 95%. With COVID-19, it is somewhere in the middle, ”he said.
“What we’ve seen during the epidemic is a lot of prior signs and press releases,” said Hahan in a separate interview with the medical journal JAMA. “We cannot make a decision based on an impression or a press release, and that’s because we insist on looking at all the raw clinical clinical data.” Traditionally, such research undergoes a peer review process prior to publication.


‘With influenza, you need immunity ranging from 60% to 70%. With measles, you need about 95%. With COVID-19, it is somewhere in the middle. ‘


– Gregory Poland, who studied immunogenetics of vaccines at the Mego Clinic

Meanwhile, the public should continue wearing masks, officials say. The COVID-19 death toll in the US may reach nearly 300,000 by December 1, but according to estimates released last week by the Institute for Health Metrics and Evaluation at the University of Washington, wearing masks continuously today is about 70,000. People’s life can be saved. School of Medicine.
“It appears that people are wearing masks and are socially disturbed more often as the infection progresses, then after a while the infection subsides, people let their guard down and protect themselves and others. Let’s stop taking these measures, which of course lead to more infections, “said HME director Christopher Murray,” and the potentially fatal cycle begins again. ”
In April – after a two-month moratorium on the efficacy of face masks, during which New York City became the epicenter of the epidemic in the US, and a month after the WHO declared an epidemic of COVID-19 – US federal authorities did. U-Turn and stated that all Americans should, after all, wear face coverings in public settings, and be aware of asymptomatic carriers.
So how contagious is COVID-19 contracted – yet does not show any symptoms? This study, published this week in the medical journal JAMA Internal Medicine, provides a theory for the first question. 303 patients with COVID-19 were isolated at a treatment center in South Korea. Of them, 110 (36%) were asymptomatic and 21 (19%) developed symptoms during isolation.
They found: “Many individuals with SARS-CoV-2 infection remained asymptomatic for a long time, and the viral load was similar to that of symptomatic patients,” the scientists concluded. “Therefore, infected individuals should be isolated regardless of symptoms.” Researchers analyzed swabs taken from the group between 6 March and 26 March.


    .

Leave a Reply

Your email address will not be published.